AKTS
Price
$20.90
Change
+$20.86 (+52150.00%)
Updated
Feb 3 closing price
Capitalization
1.09B
Intraday BUY SELL Signals
CLRO
Price
$6.11
Change
+$0.15 (+2.52%)
Updated
Feb 3 closing price
Capitalization
13.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTS vs CLRO

Header iconAKTS vs CLRO Comparison
Open Charts AKTS vs CLROBanner chart's image
Aktis Oncology
Price$20.90
Change+$20.86 (+52150.00%)
Volume$298.9K
Capitalization1.09B
ClearOne
Price$6.11
Change+$0.15 (+2.52%)
Volume$2.86K
Capitalization13.67M
AKTS vs CLRO Comparison Chart in %
CLRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKTS vs. CLRO commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a StrongBuy and CLRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (AKTS: $20.90 vs. CLRO: $6.11)
Brand notoriety: AKTS and CLRO are both not notable
AKTS represents the Biotechnology, while CLRO is part of the Telecommunications Equipment industry
Current volume relative to the 65-day Moving Average: AKTS: 61% vs. CLRO: 19%
Market capitalization -- AKTS: $1.09B vs. CLRO: $13.67M
AKTS [@Biotechnology] is valued at $1.09B. CLRO’s [@Telecommunications Equipment] market capitalization is $13.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The market cap for tickers in the [@Telecommunications Equipment] industry ranges from $328.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B. The average market capitalization across the [@Telecommunications Equipment] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTS’s FA Score shows that 0 FA rating(s) are green whileCLRO’s FA Score has 0 green FA rating(s).

  • AKTS’s FA Score: 0 green, 5 red.
  • CLRO’s FA Score: 0 green, 5 red.
According to our system of comparison, AKTS is a better buy in the long-term than CLRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRO’s TA Score shows that 6 TA indicator(s) are bullish.

  • CLRO’s TA Score: 6 bullish, 4 bearish.

Price Growth

AKTS (@Biotechnology) experienced а -1.51% price change this week, while CLRO (@Telecommunications Equipment) price change was -12.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

The average weekly price growth across all stocks in the @Telecommunications Equipment industry was +0.74%. For the same industry, the average monthly price growth was +9.60%, and the average quarterly price growth was +74.18%.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Telecommunications Equipment (+0.74% weekly)

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKTS($1.09B) has a higher market cap than CLRO($13.7M).
AKTSCLROAKTS / CLRO
Capitalization1.09B13.7M7,978%
EBITDAN/A-9.14M-
Gain YTDN/A20.039-
P/E RatioN/A1.78-
RevenueN/A11.4M-
Total CashN/A101K-
Total DebtN/A566K-
FUNDAMENTALS RATINGS
AKTS vs CLRO: Fundamental Ratings
AKTS
CLRO
OUTLOOK RATING
1..100
6872
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3443
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AKTS's Valuation (42) in the Telecommunications Equipment industry is somewhat better than the same rating for CLRO (75). This means that AKTS’s stock grew somewhat faster than CLRO’s over the last 12 months.

AKTS's Profit vs Risk Rating (59) in the Telecommunications Equipment industry is somewhat better than the same rating for CLRO (100). This means that AKTS’s stock grew somewhat faster than CLRO’s over the last 12 months.

AKTS's SMR Rating (100) in the Telecommunications Equipment industry is in the same range as CLRO (100). This means that AKTS’s stock grew similarly to CLRO’s over the last 12 months.

AKTS's Price Growth Rating (34) in the Telecommunications Equipment industry is in the same range as CLRO (43). This means that AKTS’s stock grew similarly to CLRO’s over the last 12 months.

CLRO's P/E Growth Rating (45) in the Telecommunications Equipment industry is somewhat better than the same rating for AKTS (100). This means that CLRO’s stock grew somewhat faster than AKTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRO
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 27 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PZG2.180.42
+23.86%
Paramount Gold Nevada Corp
HTLD11.080.31
+2.88%
Heartland Express
WEC112.262.42
+2.20%
WEC Energy Group
CALM85.211.30
+1.55%
Cal-Maine Foods
TKLF3.05-0.25
-7.45%
Tokyo Lifestyle Co Ltd

AKTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKTS has been loosely correlated with CGON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AKTS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTS
1D Price
Change %
AKTS100%
-4.91%
CGON - AKTS
34%
Loosely correlated
-3.28%
NBY - AKTS
33%
Loosely correlated
-32.16%
ZNTL - AKTS
27%
Poorly correlated
+12.35%
SPRY - AKTS
27%
Poorly correlated
-1.46%
CRDO - AKTS
24%
Poorly correlated
-7.21%
More

CLRO and

Correlation & Price change

A.I.dvisor tells us that CLRO and AKTS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRO and AKTS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRO
1D Price
Change %
CLRO100%
-2.55%
AKTS - CLRO
21%
Poorly correlated
-4.91%
QTRHF - CLRO
21%
Poorly correlated
+0.35%
SONM - CLRO
20%
Poorly correlated
-5.10%
SYNX - CLRO
20%
Poorly correlated
-4.59%
UI - CLRO
20%
Poorly correlated
+4.46%
More